Shuttle Pharma to Execute 10-for-1 Reverse Split on June 11, 2026
SHPH•Shuttle Pharma will implement a 10-for-1 reverse stock split on June 11, 2026, consolidating 6.37 million shares into approximately 637,108 shares at market open. The split also adjusts RSUs, warrants and convertible preferred shares, with fractional entitlements rounded up to whole shares.
1. Reverse Stock Split Details
On June 11, 2026 at 12:01 a.m. ET, Shuttle Pharma’s board approved a 10-for-1 reverse stock split of its common stock, reclassifying every ten shares into one share and assigning a new CUSIP number 825693500. Shares will trade on Nasdaq under the existing symbol on a split-adjusted basis at market open.
2. Adjustments to Equity Instruments
The reverse split applies to all issued and outstanding common shares as well as shares issuable upon exercise of RSU grants, warrants, pre-funded warrants and convertible preferred stock, consolidating approximately 6,371,075 into roughly 637,108 shares. Any fractional share entitlements will be rounded up to the next whole share at the participant level.
3. Strategic Rationale and Compliance
This action is intended to maintain compliance with Nasdaq Capital Market listing requirements and strengthen the company’s long-term capital structure by reducing the share count and potentially improving the per-share price. The consolidation supports the strategic plan to uphold market standards while positioning the platform business for sustained growth.
